Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rangnekar

Showing results (21-30 of 330) with videos related to

Pageof 33
Sort By:
Proceedings of Spie--The International Society for Optical Engineering|April 9, 2026
Random forest-based out-of-distribution detection for robust lung cancer segmentationAneesh Rangnekar, Harini Veeraraghavan
The Journal of Biological Chemistry|August 25, 1993
Interleukin-1-inducible expression of gro-beta via NF-kappa B activation is dependent upon tyrosine kinase signalingS S Joshi-Barve, V V Rangnekar, S F Sells, et al.
Cancer Biology & Therapy|May 24, 2005
Exploiting the TSA connections to overcome apoptosis-resistancePadhma Ranganathan, Vivek M Rangnekar
Current Drug Targets|March 20, 2003
Par-4 for molecular therapy of prostate cancerJames Butler, Vivek M Rangnekar
Annals of the New York Academy of Sciences|December 31, 2005
Regulation of cancer cell survival by Par-4Padhma Ranganathan, Vivek M Rangnekar
The Journal of Biological Chemistry|February 5, 1991
Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expressionV V Rangnekar, S Waheed, T J Davies, et al.
Accounts of Chemical Research|April 12, 2014
Building DNA nanostructures for molecular computation, templated assembly, and biological applicationsAbhijit Rangnekar, Thomas H LaBean
Journal of Cellular Biochemistry|February 3, 2004
Par-4 inducible apoptosis in prostate cancer cellsSushma Gurumurthy, Vivek M Rangnekar
The Journal of Biological Chemistry|November 7, 1998
The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 functionA Nalca, V M Rangnekar
Clinical Liver Disease|April 17, 2019
Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?Alexander Dao, Amol S Rangnekar
Pageof 33

Showing results (21-30 of 330) with videos related to

Sort By:
Pageof 33
Proceedings of Spie--The International Society for Optical Engineering|April 9, 2026
Random forest-based out-of-distribution detection for robust lung cancer segmentationAneesh Rangnekar, Harini Veeraraghavan
The Journal of Biological Chemistry|August 25, 1993
Interleukin-1-inducible expression of gro-beta via NF-kappa B activation is dependent upon tyrosine kinase signalingS S Joshi-Barve, V V Rangnekar, S F Sells, et al.
Cancer Biology & Therapy|May 24, 2005
Exploiting the TSA connections to overcome apoptosis-resistancePadhma Ranganathan, Vivek M Rangnekar
Current Drug Targets|March 20, 2003
Par-4 for molecular therapy of prostate cancerJames Butler, Vivek M Rangnekar
Annals of the New York Academy of Sciences|December 31, 2005
Regulation of cancer cell survival by Par-4Padhma Ranganathan, Vivek M Rangnekar
The Journal of Biological Chemistry|February 5, 1991
Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expressionV V Rangnekar, S Waheed, T J Davies, et al.
Accounts of Chemical Research|April 12, 2014
Building DNA nanostructures for molecular computation, templated assembly, and biological applicationsAbhijit Rangnekar, Thomas H LaBean
Journal of Cellular Biochemistry|February 3, 2004
Par-4 inducible apoptosis in prostate cancer cellsSushma Gurumurthy, Vivek M Rangnekar
The Journal of Biological Chemistry|November 7, 1998
The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 functionA Nalca, V M Rangnekar
Clinical Liver Disease|April 17, 2019
Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?Alexander Dao, Amol S Rangnekar
Pageof 33